when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,498 stories

Aug 27, 26Opinion: STAT+: A bill is supposed to protect U.S. biotech from Chinese competition. But there’s a loopholestat

Aug 27, 26STAT+: The mystery of Moderna’s magic algorithmstat

Aug 27, 26CAR Ts will only treat autoimmune diseases if we can scale deliverybiospace

Aug 27, 26Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drugfiercebiotech

Aug 26, 26Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDAbiopharma dive

Aug 26, 26Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pactfiercebiotech

Aug 26, 26China in Global Clinical Development: Why Early Inclusion Mattersfiercebiotech

Aug 26, 26RevMed receives early FDA approval for ‘groundbreaking’ pancreatic cancer drugbiospace

Aug 26, 26FDA approves Revolution Medicines' pancreatic cancer drugendpoints

Aug 26, 26On the fence about a statin? In borderline cases, calcium scans could be a tiebreakerstat

Aug 26, 26STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatmentstat

Aug 26, 26Research into protein interactions sheds new light on causes of autismfiercebiotech

Aug 26, 26FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancerfda press

Aug 26, 26STAT+: Key data on a new class of cardio drugs are comingstat

Aug 26, 26Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trialbiopharma dive

Aug 26, 26Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pendingbiospace

Aug 26, 26Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziiherabiospace

Aug 26, 26FDA greenlights Revolution Medicines' pancreatic cancer gamechangerfiercebiotech

Aug 26, 26Akeso, Summit hail ivonescimab's biliary tract cancer win in China-only Phase 3 trialendpoints

Aug 26, 26Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debatefiercebiotech

Aug 26, 26Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealedbiospace

Aug 26, 26Opinion: Medical aid in dying and the burden of choosing to livestat

Aug 26, 26Opinion: Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates?stat

Aug 26, 26STAT+: When it comes to women’s health, money talksstat

Aug 25, 26New Jazz cancer drug approval could drive blockbuster salesbiopharma dive

Aug 25, 26Amgen, academic centers weigh new FDA pilot to speed early drug trialsendpoints

Aug 25, 26After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platformfiercebiotech

Aug 25, 26STAT+: How Trump’s funding cuts are reshaping the health systemstat

Aug 25, 26FDA approves Jazz's Ziihera in frontline gastric cancerendpoints

Aug 25, 26STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026stat

← prevpage 18 of 50next →